TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8348874

Group type: EXPERIMENTAL
Intervention: Triazolam (2.0, 4.0, and 8.0 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol (0.25, 0.5, 1.0 g/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3522444

Group type: EXPERIMENTAL
Intervention: Calcitonin (CT) injection and placebo tablets
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Phosphate (Pi) tablets and placebo injection
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Calcitonin (CT) injection and phosphate tablets
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo injection and placebo tablets (Control group)
Number of subjects: 47
Study: 29518432

Group type: EXPERIMENTAL
Intervention: Specialized immunonutrition
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oral nutritional supplement
Number of subjects: 29
Study: 27737377

Group type: EXPERIMENTAL
Intervention: Guided physical activity three times a week and health education once a week for 16 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 33
Study: 24719064

Group type: EXPERIMENTAL
Intervention: Triple combination (TC: hydroquinone, tretinoin, and fluocinolone acetonide) treatment for 8 weeks followed by maintenance regimens (twice weekly or tapering regimen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapering regimen of TC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Twice weekly regimen of TC
Number of subjects: 0
Study: 23072083

Group type: EXPERIMENTAL
Intervention: Electroacupuncture neurostimulation therapy
Number of subjects: 48
Study: 20102355

Group type: EXPERIMENTAL
Intervention: High FODMAP diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low FODMAP diet
Number of subjects: 12
Study: 18664995

Group type: COMPARATOR
Intervention: Classroom-based psychoeducation and skills intervention (tier 1)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Classroom-based intervention and 17-session manual-based group therapy intervention (tier 2)
Number of subjects: 127
Study: 16620333

Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 150

Group type: COMPARATOR
Intervention: KY Jelly (standard lubricant)
Number of subjects: 150
Study: 12651637

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 12

Group type: COMPARATOR
Intervention: HES 70/0.5
Number of subjects: 12

Group type: COMPARATOR
Intervention: HES 200/0.5
Number of subjects: 12
Study: 10102960

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, metronidazole 400 mg, and clarithromycin 250 mg (OMC)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg (OAC)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily (O)
Number of subjects: 149
Study: 7786051

Group type: EXPERIMENTAL
Intervention: 0.30 ppm ozone during 1-h continuous exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.30 ppm ozone during 2-h intermittent exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Filtered air during 1-h continuous exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Filtered air during 2-h intermittent exercise
Number of subjects: 12
Study: 2129648

Group type: EXPERIMENTAL
Intervention: Algicon (10 ml four times daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gaviscon (20 ml four times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Algicon
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gaviscon
Number of subjects: 20
Study: 517118

Group type: EXPERIMENTAL
Intervention: DDAVP (1-desamino-8-arginine vasopressin)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 31663311

Group type: EXPERIMENTAL
Intervention: Standard preventive warm-up
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ACL rupture risk factor training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inactive arm
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 18
Study: 29723106

Group type: EXPERIMENTAL
Intervention: Catgut embedding treatment (n=45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham catgut embedding treatment (n=45)
Number of subjects: 90
Study: 27379904

Group type: EXPERIMENTAL
Intervention: Vigorous-moderate exercise
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 220
Study: 24117676

Group type: EXPERIMENTAL
Intervention: Tunnel technique with subepithelial connective tissue graft (TUN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF) with enamel matrix derivative
Number of subjects: 24
Study: 23081768

Group type: EXPERIMENTAL
Intervention: MI-via-CALC program (telephone-based, 12-week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: LEARN Program for Weight Management (lifestyle modification treatment)
Number of subjects: 45
Study: 21105279

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 18812659

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg/d
Number of subjects: 50

Group type: COMPARATOR
Intervention: lacidipine 4 mg/d
Number of subjects: 50

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 50
Study: 15762203

Group type: EXPERIMENTAL
Intervention: Self-warming lidocaine/tetracaine patch
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 100
Study: 12843889

Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporin A
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: 0.1% cyclosporin A
Number of subjects: 169

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 169
Study: 10605527

Group type: EXPERIMENTAL
Intervention: 18-month seizure-free group (n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 24-month seizure-free group (n = 39)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 80
Study: 7572699

Group type: EXPERIMENTAL
Intervention: Diet and Exercise (DE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diet alone (D)
Number of subjects: 20
Study: 1976052

Group type: EXPERIMENTAL
Intervention: 40 mg famotidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 800 mg cimetidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine
Number of subjects: 10
Study: 7031184

Group type: EXPERIMENTAL
Intervention: Phenylethylmalonamide 400 mg daily for one week
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Phenylethylmalonamide 800 mg daily for a second week
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 8
Study: 6710299

Group type: EXPERIMENTAL
Intervention: Oral neomycin and erythromycin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Systemic metronidazole and gentamicin
Number of subjects: 93
Study: 31023274

Group type: EXPERIMENTAL
Intervention: Circadian Reinforcement Therapy (CRT) combined with electronic self-monitoring (Monsenso Daybuilder System)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard group (control)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Circadian Reinforcement Therapy (CRT)
Number of subjects: 130
Study: 30234645

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PEG
Number of subjects: 100
Study: 27555173

Group type: EXPERIMENTAL
Intervention: Lavender fleur oil (LFO) aromatherapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Unscented oil (UO) aromatherapy
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both LFO and UO aromatherapy
Number of subjects: 93
Study: 24989688

Group type: EXPERIMENTAL
Intervention: Persistent allergic rhinitis (AR)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nonallergic rhinitis with eosinophilia syndrome (NARES)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Chronic rhinosinusitis with polyps (CRSwNP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Correlation between CCL24 and CCL26 levels
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (non-rhinitic volunteers)
Number of subjects: 80
Study: 22926279

Group type: EXPERIMENTAL
Intervention: Specific trunk exercise group (SEG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: General exercise group (Control)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 64
Study: 20642710

Group type: EXPERIMENTAL
Intervention: Statins (atorvastatin 10 mg, atorvastatin 80 mg, pravastatin 40 mg/day)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control (no statins)
Number of subjects: 424
Study: 17644475

Group type: EXPERIMENTAL
Intervention: Nasal CPAP with standard prenatal care
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard prenatal care alone
Number of subjects: 16
Study: 16131799

Group type: EXPERIMENTAL
Intervention: ZK 200775 (525 mg in 48 h)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ZK 200775 (105 mg over 6 h)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 12368893

Group type: EXPERIMENTAL
Intervention: Dyract (compomer)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amalgam (Contour)
Number of subjects: 60
Study: 10628893

Group type: EXPERIMENTAL
Intervention: INN 00835 (0.2 mg/kg, subcutaneously, once daily for 5 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (subcutaneously, once daily for 5 days)
Number of subjects: 35
Study: 7606653

Group type: EXPERIMENTAL
Intervention: Group counselling session (1.5-2.0 hours)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Information pamphlet
Number of subjects: 164
Study: 2205121

Group type: EXPERIMENTAL
Intervention: Ginger root
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 384241

Group type: EXPERIMENTAL
Intervention: Vitamin C (10 g per day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 150
Study: 30255369

Group type: COMPARATOR
Intervention: Conventional knee unloader brace (Unloader One®)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: New knee OA ankle brace (Agilium FreeStep®)
Number of subjects: 160
Study: 29021286

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control solution containing equivalent amount of sugars
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Pomegranate polyphenol-rich extract (supplement)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Solution containing malic and citric acid components
Number of subjects: 16
Study: 26338890

Group type: EXPERIMENTAL
Intervention: Cocoa beverage (960 mg total polyphenols; 480 mg flavanols)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Flavanol-free placebo (110 mg total polyphenols; <0.1 mg flavanols)
Number of subjects: 18
Study: 23670706

Group type: EXPERIMENTAL
Intervention: Lithium treatment (n=28)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no lithium treatment, n=32)
Number of subjects: 60
Study: 21516368

Group type: EXPERIMENTAL
Intervention: Near-miss outcomes during personal choice trials
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Near-miss outcomes
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Winning outcomes
Number of subjects: 33

Group type: COMPARATOR
Intervention: Full-misses
Number of subjects: 33
Study: 18976879

Group type: EXPERIMENTAL
Intervention: Self-weighing at least weekly
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-weighing
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Behavioral weight-loss program with telephone counseling, written manual, and home telemonitoring scale
Number of subjects: 100
Study: 17974175

Group type: EXPERIMENTAL
Intervention: Prelox
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15364747

Group type: EXPERIMENTAL
Intervention: IV amiodarone (0.73 mg/min for 48 hours) followed by oral amiodarone (400 mg q12h for 3 days)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional medical therapy (control group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Amiodarone group
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 10743904

Group type: EXPERIMENTAL
Intervention: Commonly prescribed analgesic medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UV-induced hyperalgesia model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participant-rated measures of drug liking and mood
Number of subjects: 0
Study: 8957598

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing in patients with CHF
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cardiopulmonary exercise testing in healthy subjects
Number of subjects: 35
Study: 8245113

Group type: EXPERIMENTAL
Intervention: Home-based burn treatment modality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 2951012

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 0
Study: 29615049

Group type: EXPERIMENTAL
Intervention: SB010 (10 mg bid for 28 days)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: SB010
Number of subjects: 23

Group type: COMPARATOR
Intervention: SB010 and Placebo
Number of subjects: 23
Study: 28488042

Group type: EXPERIMENTAL
Intervention: Licener® (neem extract shampoo); treated on day 1 and day 9.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Jacutin® Pedicul Fluid (dimethicone); treated on day 1 and day 9.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Combined success rate of Licener® vs Jacutin®.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Licener® vs Jacutin® in terms of ovicidal efficacy.
Number of subjects: 119
Study: 24197517

Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (Heraeus)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-power laser at low dose (30 mW, 10 J/cm², 9 s per point, 810 nm)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-power laser at high dose (100 mW, 90 J/cm², 11 s per point, 810 nm)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-power laser at low dose + Gluma Desensitizer
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-power laser at high dose + Gluma Desensitizer
Number of subjects: 27
Study: 23279603

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 30
Study: 21568831

Group type: EXPERIMENTAL
Intervention: Handling strategies
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Handling strategies + specific strength exercises
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Handling strategies + specific strength exercises + weekly physiotherapist training
Number of subjects: 37

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 37
Study: 19309586

Group type: EXPERIMENTAL
Intervention: Intensive therapy group (methylprednisolone, cyclophosphamide, Etanercept)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Intensive therapy group
Number of subjects: 136

Group type: COMPARATOR
Intervention: Normal therapy group
Number of subjects: 136
Study: 16522386

Group type: EXPERIMENTAL
Intervention: Immediate initiation of epidural analgesia at first request (221 women)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Delay of epidural until cervix dilated to at least 4 cm (228 women)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Immediate initiation of epidural analgesia
Number of subjects: 449

Group type: COMPARATOR
Intervention: Delay of epidural
Number of subjects: 449
Study: 12945019

Group type: EXPERIMENTAL
Intervention: Postoperative epidural analgesia (EA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No postoperative epidural analgesia (no EA)
Number of subjects: 1000
Study: 11098042

Group type: EXPERIMENTAL
Intervention: Laparoscopic myomectomy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Abdominal myomectomy
Number of subjects: 131
Study: 9526601

Group type: EXPERIMENTAL
Intervention: 150 micrograms fentanyl (F group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3 ml normal saline (N/S group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 mg tenoxicam (T group)
Number of subjects: 60
Study: 1286128

Group type: EXPERIMENTAL
Intervention: TTPG 180 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TTPG 540 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TTPG 1080 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TCA 180 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TCA 540 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TCA 1080 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: tiopronin 180 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: tiopronin 540 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: tiopronin 1080 mg
Number of subjects: 12
Study: 3936869

Group type: EXPERIMENTAL
Intervention: NAAGA eye-drops
Number of subjects: 50

Group type: COMPARATOR
Intervention: Disodium Cromoglycate eye-drops
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NAAGA after Cromoglycate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Disodium Cromoglycate after NAAGA
Number of subjects: 50
Study: 31163259

Group type: EXPERIMENTAL
Intervention: PCforMe (Palliative Care for Me)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (three common online resources)
Number of subjects: 80
Study: 29090731

Group type: EXPERIMENTAL
Intervention: Cadaver group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Manikin group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study: 27075276

Group type: EXPERIMENTAL
Intervention: Equine neck model for training
Number of subjects: 93
Study: 24325305

Group type: EXPERIMENTAL
Intervention: Tac (tacrolimus)
Number of subjects: 95

Group type: COMPARATOR
Intervention: CsA (cyclosporine)
Number of subjects: 95
Study: 23748259

Group type: EXPERIMENTAL
Intervention: Assessment of gustatory disorders in patients with olfactory dysfunction
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Olfactory dysfunction causes
Number of subjects: 140
Study: 20647644

Group type: EXPERIMENTAL
Intervention: OCD-algorithm
Number of subjects: 53

Group type: COMPARATOR
Intervention: Reported-algorithm
Number of subjects: 53
Study: 18029343

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without PGS
Number of subjects: 0
Study: 16912706

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (current immunosuppressive treatment)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sirolimus (in patients with proteinuria)
Number of subjects: 25
Study: 14671148

Group type: EXPERIMENTAL
Intervention: Pegvisomant-induced serum IGF-I normalization
Number of subjects: 16
Study: 10951338

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1250 mg/m² and vinorelbine 25 mg/m² administered on Days 1 and 8 every 3 weeks for up to 9 courses
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine
Number of subjects: 54
Study: 7941897

Group type: EXPERIMENTAL
Intervention: Adjuvant intramuscular immunoglobulin against tick‐borne encephalitis
Number of subjects: 115

Group type: COMPARATOR
Intervention: Nonspecific treatment alone
Number of subjects: 115
Study: 2895840

Group type: EXPERIMENTAL
Intervention: 400 mg twice a day
Number of subjects: 131

Group type: COMPARATOR
Intervention: 200 mg four times a day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 200 mg once a day
Number of subjects: 131

Group type: COMPARATOR
Intervention: Before treatment
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: During treatment
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: After stopping treatment
Number of subjects: 131
Study: 29730907

Group type: EXPERIMENTAL
Intervention: Iso‐Tome® precut (IT‐P)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Needle‐knife precut fistulotomy (NK‐F)
Number of subjects: 239
Study: 28666335

Group type: EXPERIMENTAL
Intervention: Ginger 160 mg/day
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 23812286

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flexible single-incision surgery (FSIS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional laparoscopy (CL)
Number of subjects: 60
Study: 21088973

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous resistance exercise (M-VR)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-intensity aerobic exercise (LA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous aerobic exercise (M-VA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-intensity resistance exercise (LR)
Number of subjects: 12
Study: 19298585

Group type: EXPERIMENTAL
Intervention: TZP-101 (80, 160, 320 or 600 microg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17951928

Group type: EXPERIMENTAL
Intervention: Chlorhexidine and sodium fluoride mouthrinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse alone
Number of subjects: 0
Study: 14980746

Group type: COMPARATOR
Intervention: risperidone
Number of subjects: 5
Study: 11513305

Group type: EXPERIMENTAL
Intervention: Cold dive to 50 m
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comfortable temperature dive to 50 m
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cold dive to 10 m
Number of subjects: 26
Study: 9773132

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2.5 mg/ml
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bupivacaine 2.5 mg/ml
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both ropivacaine and bupivacaine
Number of subjects: 24
Study: 8582131

Group type: EXPERIMENTAL
Intervention: Metformin (2 x 850 mg day-1 for 2 days and 850 mg 1 h before evaluation)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1967226

Group type: EXPERIMENTAL
Intervention: Flumazenil (Ro 15‐1788)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40